Health and FitnessHealth and Fitness
Mon, December 17, 2012
[ Mon, Dec 17th 2012 ] - Market Wire
Mindoro to Appoint New CEO
[ Mon, Dec 17th 2012 ] - Market Wire
Swordfish Goes Hollywood
[ Mon, Dec 17th 2012 ] - Market Wire
APPLICATION ANNOUNCEMENT
[ Mon, Dec 17th 2012 ] - Market Wire
'Will Apple Keep Going Lower?'

Dynavax to Present at the 31st Annual J.P. Morgan Healthcare Conference


Published on 2012-12-17 06:45:36 - Market Wire
  Print publication without navigation


December 17, 2012 09:30 ET

Dynavax to Present at the 31st Annual J.P. Morgan Healthcare Conference

BERKELEY, CA--(Marketwire - Dec 17, 2012) - Dynavax Technologies Corporation (NASDAQ: [ DVAX ]) announced today that it will present at the 31st Annual J.P. Morgan Healthcare Conference in San Francisco on Monday, January 7, 2013 at 6:00 p.m. Eastern Time (3:00 p.m. Pacific Time).

Dino Dina, M.D., Chief Executive Officer of Dynavax, will provide a company overview. To access the slide presentation, live webcast, and subsequent archived recording, please visit Dynavax's website at [ http://investors.dynavax.com/newsevents.cfm ].

About Dynavax

Dynavax, a clinical-stage biopharmaceutical company, discovers and develops novel products to prevent and treat infectious and inflammatory diseases. Dynavax's lead product candidate is HEPLISAV, a Phase 3 investigational adult hepatitis B vaccine. For more information visit [ www.dynavax.com ].